Nanosynex is developing a diagnostic test that detects bacterial resistance to antibiotics using microfluidics technology, based on research from the Technion – Israel Institute of Technology. The company’s platform aims to deliver faster and more accurate results than traditional methods, helping clinicians make timely and effective treatment decisions.